Thursday, September 9, 1999
Ranbaxy signs $50 mn deal with Bayer
Ranbaxy Laboratories has entered into a strategic alliance with Bayer AG which gives Bayer exclusive development and worldwide marketing rights (except for India and CIS countries) for a new oral formulation of antibiotic drug - Ciprofloxacin.
S&P revises ICICI rating to stable from negative
The international rating agency Standard & Poor's (S&P) has affirmed ICICI Ltd's foreign currency debt rating and has revised the outlook to stable from negative.
Indian Bank loses Rs 2,815 crore in 4 years
If you're looking for the most visible sign of the rot in the Ministry of Finance, or the way in which the economy has been allowed to run down right from Dr Manmohan Singh's times, your best bet is to look at Indian Bank.
|
|
